Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-12-002804
Filing Date
2012-01-18
Accepted
2012-01-18 16:30:45
Documents
1
Period of Report
2012-01-15

Document Format Files

Seq Description Document Type Size
1 form447514_20120118043008-.html 4  
1 form447514_20120118043008-.xml 4 7310
  Complete submission text file 0001144204-12-002804.txt   8673
Mailing Address 99 HUDSON STREET 5TH FLOOR NEW YORK NY 10013
Business Address 99 HUDSON STREET 5TH FLOOR NEW YORK NY 10013 (212) 554-4388
VENTRUS BIOSCIENCES INC (Issuer) CIK: 0001426800 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VENTRUS BIOSCIENCES, INC. 787 7TH AVENUE, 48TH FLOOR NEW YORK NY 10019
Business Address
Rowland Thomas Andrew (Reporting) CIK: 0001507496 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35005 | Film No.: 12532409